Mission Fulphila - Mylan-Biocon Biosimilar Neulasta Takes The Stage In US

The first FDA-approved Neulasta biosimilar is here, opening up material earnings opportunities for partners Mylan and Biocon and affirming the duo's ability to deliver on their complex but high-value pipeline.